ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,186, issued on Aug. 5, was assigned to Vivoryon Therapeutics N.V. (Halle, Germany).
"Inhibitors of meprin Alpha and Beta" was invented by Michael Wermann (Halle, Germany), Mirko Buchholz (Halle, Germany), Hans-Ulrich Demuth (Halle, Germany), Daniel Ramsbeck (Halle, Germany), Dagmar Schlenzig (Halle, Germany) and Stephan Schilling (Halle, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel hydroxamic acid derivatives as inhibitors of meprin Beta and/or Alpha, pharmaceutical compositions comprising such compounds, methods for treatment or prophylaxis of diseases or conditions, especially such that are related t...